Buy Neurocrine Biosciences Stock | NBIX Stock Price & Latest News | Public.com
NBIX

Neurocrine Biosciences

$0.00 (0.00%)Today
    View Neurocrine Biosciences (NBIX) stock trends here

    About NBIX

    Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The firm's product includes INGREZZA. The company...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    3.58
    2.18
    0.78
    -0.62
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    $0.73

    Actual EPS
    Q2 2021

    Stats

    Market Cap$9,13B
    Volume502k
    Price-to-Earnings Ratio23.23
    Dividend Rate
    Dividend Yield
    1 Year High$136.26
    1 Year Low$86.02
    Open$96.42
    High$96.89
    Low$94.61

    Buy any stock with any amount of money.

    Download the App
    Download the app